AI leaders call for tougher protections against AI-aided bioweapons
Source: The Verge
Background
Some of the AI industry’s biggest rivals have set aside their many grievances for a common cause: making it harder for people to use their technology to develop biological weapons. In an open letter to U.S. lawmakers, tech leaders are pressing Congress to enact rules that close what they describe as an alarming biosecurity gap that could help trigger a global pandemic.
Signatories
- Anthropic – Dario Amodei
- OpenAI – Sam Altman
- Microsoft – Mustafa Suleyman
- Meta – AI chief Alexandr Wang
- Google DeepMind – Demis Hassabis (2024 Nobel Prize in Chemistry for AI‑based protein prediction)
The letter was also signed by prominent scientists, national‑security and policy experts, and executives from biotech companies including Twist Bioscience and Ansa Biotechnologies, both major sellers of synthetic genetic material. It was reportedly organized by two think tanks: the Foundation for American Innovation and the Institute for Progress.
Scientific Concerns
Scientists have long warned that advances in synthetic biology could make it easier to engineer dangerous organisms or even resurrect long‑dead pathogens. Historically, such power has remained in the hands of skilled researchers with access to sophisticated labs, equipment, and resources.
Now, as biological tools become cheaper and more accessible and AI models become more capable, the barriers preventing misuse are beginning to crumble. Experts also note that AI could facilitate the creation of other threats, such as chemical weapons.
Policy Recommendations
While many of the largest providers of synthetic DNA and RNA already screen orders, this screening is currently voluntary, not mandatory. The letter calls for:
- Mandatory screening of purchases for sequences that could be used to make dangerous pathogens.
- Detailed record‑keeping of all orders to track any threats that evade initial screening.
“Given the pace at which the underlying technology is changing, we believe the need is urgent,” the letter states. “This is a rare moment of agreement across stakeholders that are often at odds. We hope policymakers will meet it with decisive action.”